Diabetes 68(6):11211129 Grespan E, Giorgino T, Natali A, Ferrannini E, Mari A (2021) Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes
The authors noted NNMT overexpression in many human malignancies and described 5-Amino-1MQ as a novel NNMT inhibitor with promising results across obesity and cancer cell research models
Themes & trends Across our 150 selected companies, we identified key themes and trends that highlight their efforts to transform the healthcare industry
A GLP-1 refers to a class of medications that mimics the naturally occurring hormone Glucagon-like peptide-1
NovoMix is also known as Novolog Mix
A 2026 review published in Andrology consolidated the mechanistic evidence: kisspeptin modulation of GnRH pulsatility represents a testable biomarker pathway for differentiating PMOS from functional hypothalamic amenorrhea, and potentially for targeted therapeutic intervention